{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:11:15Z","timestamp":1787242275977,"version":"build-2736575974"},"reference-count":41,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The hemoglobinopathies encompass a heterogeneous group of disorders associated with mutations in both the alpha-globin and beta-globin genes. Non-sickling disorders are found primarily in individuals of Mediterranean, Asian and Southeast Asian ancestry. With rapid growth in the Asian and Hispanic segments of the US population, the geographic distribution of hemoglobinopathies is expected to become significantly different from what it is today. The epidemiologic changes in the prevalence of non-sickling hemoglobin disorders have important implications for future public health programs, including newborn screening.<\/jats:p>\n                  <jats:p>The purpose of newborn screening for hemoglobinopathies is to identify clinically significant disorders and provide early education and specialized care prior to the onset of clinical symptoms. Although newborn screening for sickle cell disease is mandated in all states, screening for non-sickling hemoglobinopathies is directed in only one state and limited to reporting of a presumptive diagnosis in most other states. Early delivery of comprehensive care, as well as new and potentially curative therapies, has significantly improved the prognosis for affected patients. This review will consider the increasing prevalence of once uncommon hemoglobinopathies in the US, highlighting the rationale for expanding newborn screening beyond sickle cell disorders.<\/jats:p>","DOI":"10.1182\/asheducation-2009.1.19","type":"journal-article","created":{"date-parts":[[2009,12,11]],"date-time":"2009-12-11T15:35:31Z","timestamp":1260545731000},"page":"19-25","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":37,"title":["Newborn screening for non-sickling hemoglobinopathies"],"prefix":"10.1182","volume":"2009","author":[{"given":"Carolyn C.","family":"Hoppe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111704230257700_R1","doi-asserted-by":"crossref","unstructured":"Newborn screening: toward a uniform screening panel and system\u2014executive summary. Pediatrics. 2006;117:S296\u2013307.","DOI":"10.1542\/peds.2005-2633I"},{"key":"2019111704230257700_R2","doi-asserted-by":"crossref","unstructured":"Gaston MH, Verter JI, Woods G, et al. Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial. N Engl J Med. 1986;314:1593\u20131599.","DOI":"10.1056\/NEJM198606193142501"},{"key":"2019111704230257700_R3","unstructured":"Frempong T, Pearson HA. Newborn screening coupled with comprehensive follow-up reduced early mortality of sickle cell disease in Connecticut. Conn Med. 2007;71:9\u201312."},{"key":"2019111704230257700_R4","doi-asserted-by":"crossref","unstructured":"Lee A, Thomas P, Cupidore L, Serjeant B, Serjeant G. Improved survival in homozygous sickle cell disease: lessons from a cohort study. BMJ. 1995;311:1600\u20131602.","DOI":"10.1136\/bmj.311.7020.1600"},{"key":"2019111704230257700_R5","doi-asserted-by":"crossref","unstructured":"Telfer P, Coen P, Chakravorty S, et al. Clinical outcomes in children with sickle cell disease living in England: a neonatal cohort in East London. Haematologica. 2007;92:905\u2013912.","DOI":"10.3324\/haematol.10937"},{"key":"2019111704230257700_R6","doi-asserted-by":"crossref","unstructured":"Vichinsky E, Hurst D, Earles A, Kleman K, Lubin B. Newborn screening for sickle cell disease: effect on mortality. Pediatrics. 1988;81:749\u2013755.","DOI":"10.1542\/peds.81.6.749"},{"key":"2019111704230257700_R7","doi-asserted-by":"crossref","unstructured":"Basran RK, Patterson M, Walker L, et al. Prenatal diagnosis of hemoglobinopathies in Ontario, Canada. Ann N Y Acad Sci. 2005;1054:507\u2013510.","DOI":"10.1196\/annals.1345.052"},{"key":"2019111704230257700_R8","doi-asserted-by":"crossref","unstructured":"Li D, Liao C, Li J, et al. Prenatal diagnosis of beta-thalassemia in Southern China. Eur J Obstet Gynecol Reprod Biol. 2006;128:81\u201385.","DOI":"10.1016\/j.ejogrb.2005.11.016"},{"key":"2019111704230257700_R9","doi-asserted-by":"crossref","unstructured":"Rappaport VJ, Velazquez M, Williams K. Hemoglobinopathies in pregnancy. Obstet Gynecol Clin North Am. 2004;31:287\u2013317.","DOI":"10.1016\/j.ogc.2004.03.006"},{"key":"2019111704230257700_R10","doi-asserted-by":"crossref","unstructured":"Luo HY, Boudreaux J, Steinberg MH, Chui DH. Patients with thalassemia in the United States. Blood. 2005;105:4896\u20134897.","DOI":"10.1182\/blood-2005-03-0856"},{"key":"2019111704230257700_R11","unstructured":"Schoen EJ, Marks SM, Clemons MM, Bachman RP. Comparing prenatal and neonatal diagnosis of hemoglobinopathies. Pediatrics. 1993;92:354\u2013357."},{"key":"2019111704230257700_R12","doi-asserted-by":"crossref","unstructured":"McCabe LL, Therrell BL Jr, McCabe ER. Newborn screening: rationale for a comprehensive, fully integrated public health system. Mol Genet Metab. 2002;77:267\u2013273.","DOI":"10.1016\/S1096-7192(02)00196-8"},{"key":"2019111704230257700_R13","doi-asserted-by":"crossref","unstructured":"Tough SC, Siever JE, Johnston DW. Retaining women in a prenatal care randomized controlled trial in Canada: implications for program planning. BMC Public Health. 2007;7:148.","DOI":"10.1186\/1471-2458-7-148"},{"key":"2019111704230257700_R14","doi-asserted-by":"crossref","unstructured":"Vichinsky EP, MacKlin EA, Waye JS, Lorey F, Olivieri NF. Changes in the epidemiology of thalassemia in North America: a new minority disease. Pediatrics. 2005;116:e818\u2013825.","DOI":"10.1542\/peds.2005-0843"},{"key":"2019111704230257700_R15","unstructured":"Dynamic Diversity: Projected Changes in U.S. Race and Ethnic Composition 1995 to 2050: U.S. Census Bureau; 1999. Accessed at http:\/\/www.mbda.gov\/documents\/unpubtext.pdf"},{"key":"2019111704230257700_R16","unstructured":"Yearbook of Immigration Statistics, 2003: U.S. Department of Homeland Security; 2004. Accessed at http:\/\/www.dhs.gov\/files\/statistics\/publications\/archive.shtm"},{"key":"2019111704230257700_R17","doi-asserted-by":"crossref","unstructured":"Weatherall DJ. Hemoglobinopathies worldwide: present and future. Curr Mol Med. 2008;8:592\u2013599.","DOI":"10.2174\/156652408786241375"},{"key":"2019111704230257700_R18","unstructured":"2007 American Community Survey and Census Data on the Foreign Born by State: Migration Policy Institute; 2007. Accessed at http:\/\/www.migrationinformation.org\/dataHub\/acscensus.cfm"},{"key":"2019111704230257700_R19","doi-asserted-by":"crossref","unstructured":"Michlitsch J, Azimi M, Hoppe C, et al. Newborn screening for hemoglobinopathies in California. Pediatr Blood Cancer. 2009;52:486\u2013490.","DOI":"10.1002\/pbc.21883"},{"key":"2019111704230257700_R20","doi-asserted-by":"crossref","unstructured":"Lorey F, Cunningham G, Vichinsky EP, et al. Universal newborn screening for Hb H disease in California. Genet Test. 2001;5:93\u2013100.","DOI":"10.1089\/109065701753145538"},{"key":"2019111704230257700_R21","doi-asserted-by":"crossref","unstructured":"Shafer FE, Lorey F, Cunningham GC, Klumpp C, Vichinsky E, Lubin B. Newborn screening for sickle cell disease: 4 years of experience from California\u2019s newborn screening program [see comments]. J Pediatr Hematol Oncol. 1996;18:36\u201341.","DOI":"10.1097\/00043426-199602000-00007"},{"key":"2019111704230257700_R22","doi-asserted-by":"crossref","unstructured":"Lane PA, Eckman JR. Cost-effectiveness of neonatal screening for sickle cell disease. J Pediatr. 1992;120:162\u2013163.","DOI":"10.1016\/S0022-3476(05)80628-6"},{"key":"2019111704230257700_R23","doi-asserted-by":"crossref","unstructured":"Dumars KW, Boehm C, Eckman JR, Giardina PJ, Lane PA, Shafer FE. Practical guide to the diagnosis of thalassemia. Council of Regional Networks for Genetic Services (CORN). Am J Med Genet. 1996;62:29\u201337.","DOI":"10.1002\/(SICI)1096-8628(19960301)62:1<29::AID-AJMG7>3.0.CO;2-R"},{"key":"2019111704230257700_R24","doi-asserted-by":"crossref","unstructured":"Singer ST, Kuypers FA, Olivieri NF, et al. Fetal haemoglobin augmentation in E\/beta(0) thalassaemia: clinical and haematological outcome. Br J Haematol. 2005;131:378\u2013388.","DOI":"10.1111\/j.1365-2141.2005.05768.x"},{"key":"2019111704230257700_R25","doi-asserted-by":"crossref","unstructured":"Fucharoen S, Ketvichit P, Pootrakul P, Siritanaratkul N, Piankijagum A, Wasi P. Clinical manifestation of beta-thalassemia\/hemoglobin E disease. J Pediatr Hematol Oncol. 2000;22:552\u2013557.","DOI":"10.1097\/00043426-200011000-00022"},{"key":"2019111704230257700_R26","doi-asserted-by":"crossref","unstructured":"Aessopos A, Kati M, Farmakis D. Heart disease in thalassemia intermedia: a review of the underlying pathophysiology. Haematologica. 2007;92:658\u2013665.","DOI":"10.3324\/haematol.10915"},{"key":"2019111704230257700_R27","doi-asserted-by":"crossref","unstructured":"Chui DH, Fucharoen S, Chan V. Hemoglobin H disease: not necessarily a benign disorder. Blood. 2003;101:791\u2013800.","DOI":"10.1182\/blood-2002-07-1975"},{"key":"2019111704230257700_R28","doi-asserted-by":"crossref","unstructured":"Li DZ, Liao C. A case of transfusion-dependent nondeletional Hb H disease undiagnosed during prenatal screening for thalassemia. Prenat Diagn. 2008;28:165\u2013166.","DOI":"10.1002\/pd.1947"},{"key":"2019111704230257700_R29","doi-asserted-by":"crossref","unstructured":"Cohen AR, Galanello R, Pennell DJ, Cunningham MJ, Vichinsky E. Thalassemia. Hematology Am Soc Hematol Educ Program. 2004:14\u201334.","DOI":"10.1182\/asheducation-2004.1.14"},{"key":"2019111704230257700_R30","doi-asserted-by":"crossref","unstructured":"Feuchtbaum L, Lorey F, Faulkner L, et al. California\u2019s experience implementing a pilot newborn supplemental screening program using tandem mass spectrometry. Pediatrics. 2006;117:S261\u2013269.","DOI":"10.1542\/peds.2005-2633E"},{"key":"2019111704230257700_R31","unstructured":"National Institutes of Health. Neonatal screening. In: Management of Sickle Cell Disease. 4th ed. NIH Publ. 02-2117; 2002. Accessed at http:\/\/www.nhlbi.nih.gov\/health\/prof\/blood\/sickle\/sc_mngt.pdf"},{"key":"2019111704230257700_R32","unstructured":"Giordano PC, Harteveld CL. Chromatographic measurements of memoglobin A2 in blood samples containing sickle hemoglobin. Ann Clin Lab Sci. 2000;30:430\u2013431."},{"key":"2019111704230257700_R33","doi-asserted-by":"crossref","unstructured":"Bhardwaj U, Zhang YH, McCabe ER. Neonatal hemoglobinopathy screening: molecular genetic technologies. Mol Genet Metab. 2003;80:129\u2013137.","DOI":"10.1016\/j.ymgme.2003.08.014"},{"key":"2019111704230257700_R34","unstructured":"Weatherall DJ. The thalassemias. In: Stamatoyannopoulos G, Nienhuis AW, eds. The Molecular Basis of Blood Diseases. 2nd Edition. Philadelphia: W.B. Saunders; 1994:157\u2013160."},{"key":"2019111704230257700_R35","unstructured":"Kham SK, Quah TC, Loong AM, et al. A molecular epidemiologic study of thalassemia using newborns\u2019 cord blood in a multiracial Asian population in Singapore: results and recommendations for a population screening program. J Pediatr Hematol Oncol. 2004;26:817\u2013819."},{"key":"2019111704230257700_R36","doi-asserted-by":"crossref","unstructured":"Tsuchihashi Z, Dracopoli NC. Progress in high throughput SNP genotyping methods. Pharmacogenomics J. 2002;2:103\u2013110.","DOI":"10.1038\/sj.tpj.6500094"},{"key":"2019111704230257700_R37","doi-asserted-by":"crossref","unstructured":"Liu JZ, Han H, Schouten JP, et al. Detection of alpha-thalassemia in China by using multiplex ligation-dependent probe amplification. Hemoglobin. 2008;32:561\u2013571.","DOI":"10.1080\/03630260802508111"},{"key":"2019111704230257700_R38","doi-asserted-by":"crossref","unstructured":"Green NS, Pass KA. Neonatal screening by DNA microarray: spots and chips. Nat Rev Genet. 2005;6:147\u2013151.","DOI":"10.1038\/nrg1526"},{"key":"2019111704230257700_R39","doi-asserted-by":"crossref","unstructured":"Creary LE, McKenzie CA, Menzel S, et al. Ethnic differences in F cell levels in Jamaica: a potential tool for identifying new genetic loci controlling fetal haemoglobin. Br J Haematol. 2009;144:954\u2013960.","DOI":"10.1111\/j.1365-2141.2008.07532.x"},{"key":"2019111704230257700_R40","doi-asserted-by":"crossref","unstructured":"Thein SL. Genetic modifiers of the beta-haemoglobinopathies. Br J Haematol. 2008;141:357\u2013366.","DOI":"10.1111\/j.1365-2141.2008.07084.x"},{"key":"2019111704230257700_R41","doi-asserted-by":"crossref","unstructured":"Bethell CD, Read D, Brockwood K. Using existing population-based data sets to measure the American Academy of Pediatrics definition of medical home for all children and children with special health care needs. Pediatrics. 2004;113:1529\u20131537.","DOI":"10.1542\/peds.113.S4.1529"}],"container-title":["Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2009\/1\/19\/645525\/019_025ash.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2009\/1\/19\/645525\/019_025ash.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T17:36:59Z","timestamp":1685209019000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/hematology\/article\/2009\/1\/19\/19864\/Newborn-screening-for-nonsickling"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1,1]]}},"URL":"https:\/\/doi.org\/10.1182\/asheducation-2009.1.19","relation":{},"ISSN":["1520-4391","1520-4383"],"issn-type":[{"value":"1520-4391","type":"print"},{"value":"1520-4383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,1]]}}}